Larvol Delta - Proteomic-analyses-in-the-Phase-2-ARGO-trial-identify-IL-17-signalingassociated-markers-linked-to-disease-activity-treatment-response-to-sonelokimab-and-pharmacodynamic-changes-in-psoriatic-arthritis

sonelokimab (M1095) - Avillion, MoonLake Immunotherap

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1899396&mode=presInfo

Iain B. McInnes, Professor

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next